Literature DB >> 12085104

Suppression of metastasis of rat prostate cancer by introduction of human chromosome 13.

Shigeru Hosoki1, Sho Ota, Yayoi Ichikawa, Hiroyoshi Suzuki, Takeshi Ueda, Yukio Naya, Koichiro Akakura, Tatsuo Igarashi, Mitsuo Oshimura, Naoki Nihei, J Carl Barrett, Tomohiko Ichikawa, Haruo Ito.   

Abstract

AIM: Chromosome 13 is one of the most frequently altered chromosomes in prostate cancer. The present study was undertaken to examine the role of human chromosome 13 in the progression of prostate cancer.
METHODS: Human chromosome 13 was introduced into highly metastatic rat prostate cancer cells via microcell-mediated chromosome transfer.
RESULTS: Microcell hybrid clones containing human chromosome 13 showed suppression of metastasis to the lung without any suppression of tumorigenicity, except for one clone, which contained the smallest sized human chromosome 13 and did not show any suppression on lung metastasis. Expression of two known tumor suppressor genes, BRCA2 and RB1, which map to chromosome 13, was examined by reverse transcription- polymerase chain reaction analysis. BRCA2 was expressed only in the metastasis-suppressed microcell-hybrid clones, whereas RB1 was expressed in all clones.
CONCLUSION: Human chromosome 13 contains metastasis suppressor gene(s) for prostate cancer derived from rat. Furthermore, the RB1 gene is unlikely to be involved in the suppression of metastasis evident in this system.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12085104

Source DB:  PubMed          Journal:  Asian J Androl        ISSN: 1008-682X            Impact factor:   3.285


  5 in total

1.  MKK4 suppresses metastatic colonization by multiple highly metastatic prostate cancer cell lines through a transient impairment in cell cycle progression.

Authors:  Russell Z Szmulewitz; Robert Clark; Tamara Lotan; Kristen Otto; Jennifer Taylor Veneris; Kay Macleod; Carrie Rinker-Schaeffer
Journal:  Int J Cancer       Date:  2011-04-25       Impact factor: 7.396

2.  Somatic Mutation Profiling of Intrahepatic Cholangiocarcinoma: Comparison between Primary and Metastasis Tumor Tissues.

Authors:  Shi-Feng Xu; Yuan Guo; Xin Zhang; Xiao-Dan Zhu; Ning Fan; Zhi-Lei Zhang; Gui-Bing Ren; Wei Rao; Yun-Jin Zang
Journal:  J Oncol       Date:  2020-09-17       Impact factor: 4.375

3.  Normal viability of Kai1/Cd82 deficient mice.

Authors:  John I Risinger; Mary Custer; Lionel Feigenbaum; R Mark Simpson; Shelley B Hoover; Joshua D Webster; Gadisetti V R Chandramouli; Lino Tessarollo; J Carl Barrett
Journal:  Mol Carcinog       Date:  2013-02-08       Impact factor: 4.784

4.  DIAPH3 governs the cellular transition to the amoeboid tumour phenotype.

Authors:  Martin H Hager; Samantha Morley; Diane R Bielenberg; Sizhen Gao; Matteo Morello; Ilona N Holcomb; Wennuan Liu; Ghassan Mouneimne; Francesca Demichelis; Jayoung Kim; Keith R Solomon; Rosalyn M Adam; William B Isaacs; Henry N Higgs; Robert L Vessella; Dolores Di Vizio; Michael R Freeman
Journal:  EMBO Mol Med       Date:  2012-05-16       Impact factor: 12.137

Review 5.  Studies of Tumor Suppressor Genes via Chromosome Engineering.

Authors:  Hiroyuki Kugoh; Takahito Ohira; Mitsuo Oshimura
Journal:  Cancers (Basel)       Date:  2015-12-30       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.